Overview

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purposes of this study were to assess Quality of Life (QoL) and urination urge, incontinence, and micturition frequency including nocturia after 4 and 12 weeks treatment with propiverine.
Details
Lead Sponsor:
Takeda
Treatments:
Propiverine